Trusted by:
Reach targeted audiences faster and more effectively with access to Acclinate’s diverse, 100K-strong online community and existing activation points. No matter the specific qualifications of your trial, we’ll help you locate, educate, and engage just the right people.
Check out NOWINCLUDED
Accessed
Engaged
Typical recruitment uses cognitive trust to help people feel confident in joining a trial. However, communities of color may be skeptical. Acclinate’s NOWINCLUDED platform primes community members with information on conditions, health resources, and a place to connect. The platform aims to empower members to take control of their medical journeys, creating affective – emotional, and communal – trust.
See How it WorksAcclinate gives research sponsors the keys to unlock stellar DEI in clinical trials – access to hard-to-reach communities and technology to cultivate and engage the right groups. It's essential to separate sustained community engagement from the recruitment process and leverage conversion metrics to establish a strong connection between the two.
Acclinate doubles down on sustained community engagement tactics that correlate highly with recruitment, enrollment, and retention.
Acclinate’s extensive data set, analytics, and predictive AI software give you the insights to help you plan and place future trials in just the right locations.
See How it WorksAcclinate’s increase in total pre-screened patients, accomplished in a third of the time.
Of those who passed the prescreener answered a call from Acclinate expressing interest in participating.
Sometimes, people do not know how to gain access to clinical trials. Our partnership with Acclinate leverage[d] their established, trusted community connections, digital platform, and app with Lightship’s robust clinical trial infrastructure and commitment to meeting participants where they are to deliver their clinical trial.
David MacMurchy
CEO, Lightship
How to invest resources into diversity upfront
Design trials for communities of color
Understand the communities you’re working with
Humans aren’t homogenous. Taking our differences into account when researching vital medical treatments means better care for groups that have often been “left out” of mainstream clinical research.
A broader test pool means more information – and an increased ability to assess drug efficacy and negative reactions before going to market.
© 2024 Acclinate. All rights reserved. Privacy Policy
